| NCT01099839 | Healthy Volunteers|Pharmacokinetics of ASP1941 | Drug: ASP1941|Drug: Miglitol | Astellas Pharma Inc | Phase 1 | 2010-02-01 | 2010-06-08 |
| NCT00213122 | Type 2 Diabetes Mellitus | Drug: miglitol | Sanwa Kagaku Kenkyusho Co., Ltd. | Phase 3 | null | 2006-09-25 |
| NCT00380822 | Type 2 Diabetes Mellitus | Drug: miglitol | Sanwa Kagaku Kenkyusho Co., Ltd. | Phase 3 | null | 2006-09-25 |
| NCT00213109 | Type 1 Diabetes Mellitus | Drug: Miglitol | Sanwa Kagaku Kenkyusho Co., Ltd. | Phase 3 | null | 2006-09-20 |
| NCT00334503 | Type 2 Diabetes Mellitus | Drug: Miglitol | Sanwa Kagaku Kenkyusho Co., Ltd. | Phase 3 | null | 2008-10-08 |
| NCT00213070 | Type 2 Diabetes Mellitus | Drug: Miglitol | Sanwa Kagaku Kenkyusho Co., Ltd. | Phase 3 | null | 2006-09-20 |
| NCT00334399 | Type 2 Diabetes Mellitus | Drug: Miglitol | Sanwa Kagaku Kenkyusho Co., Ltd. | Phase 3 | null | 2008-10-08 |
| NCT01242202 | Type 2 Diabetes Mellitus | Drug: ASP1941|Drug: alpha glucosidase inhibitor | Astellas Pharma Inc | Phase 3 | 2010-10-01 | 2016-01-18 |
| NCT02669693 | Diabetes | Dietary Supplement: bread without olives|Dietary Supplement: bread with olives | University of Leeds | | 2015-12-01 | 2017-03-22 |
| NCT01697592 | Type 2 Diabetes Mellitus | Drug: Omarigliptin|Drug: Matching placebo to omarigliptin | Merck Sharp & Dohme Corp. | Phase 3 | 2012-10-01 | 2016-10-28 |
| NCT02475499 | Diabetes Mellitus, Type 2 | Drug: DPP-4 inhibitors|Drug: GLP-1 analogs|Drug: Sulfonylureas|Drug: Biguanides|Drug: Thiazolidinediones|Drug: Alpha-glucosidase inhibitors|Drug: Meglitinides | Canadian Network for Observational Drug Effect Studies, CNODES|Drug Safety and Effectiveness Network, Canada|Canadian Institutes of Health Research (CIHR) | | 2014-03-01 | 2016-03-11 |
| NCT02476760 | Diabetes Mellitus, Type 2 | Drug: DPP-4 inhibitors|Drug: GLP-1 analogs|Drug: Insulins|Drug: Biguanides|Drug: Sulfonylureas|Drug: Thiazolidinediones|Drug: Alpha-glucosidase inhibitors|Drug: Meglitinides | Canadian Network for Observational Drug Effect Studies, CNODES|Drug Safety and Effectiveness Network, Canada|Canadian Institutes of Health Research (CIHR) | | 2014-03-01 | 2016-11-01 |
| NCT02456428 | Type 2 Diabetes Mellitus | Drug: DPP-4 inhibitors|Drug: GLP-1 analogs|Drug: Insulins|Drug: Biguanides|Drug: Sulfonylureas|Drug: Thiazolidinediones|Drug: Alpha-glucosidase inhibitors|Drug: Meglitinides | Canadian Network for Observational Drug Effect Studies, CNODES|Drug Safety and Effectiveness Network, Canada|Canadian Institutes of Health Research (CIHR) | | 2014-03-01 | 2016-04-15 |
